Skip to Main Content

Paper Details

Nasal and Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Levels Are Associated With Timing of Symptom Resolution in the ACTIV-2 Trial of Nonhospitalized Adults With Coronavirus Disease 2019.
Clin Infect Dis
3
2023
COVID, COVID-19, Plasma, SARS-, SARS-CoV-2, SARS-CoV-2 RNA, anterior nasal (AN) RNA, plasma RNA
Author NameAffiliation
Judith S CurrierDavid Geffen School of Medicine at University of California los angeles
Judith S CurrierDavid Geffen School of Medicine at University of California los angeles
David A WohlUniversity of North Carolina at Chapel Hill School of Medicine
Eric S DaarLundquist Institute at Harbor-university of california los angeles Medical Center
Joseph J EronUniversity of North Carolina at Chapel Hill School of Medicine
  • 1 - 5

Datasets

Release 1.2